The mechanisms of drug resistance in prostate cancer
He, Y.; Liu, Y.-g.; Cen, S.; Zhou, J.-m.
Yao Xue Xue Bao 50(7): 797-801
2015
ISSN/ISBN: 0513-4870 PMID: 26552138 Document Number: 685553
Drug therapy is one of the efficient methods for prostate cancer treatment. However, drug resistance greatly hindered the treatment of prostate cancer patients. Herein, the mechanisms of drug resistance in prostate cancer have been exhaustively reviewed, and that can provide an alternative strategy and new targets for anti-prostate cancer therapy.
Document emailed within 1 workday
Related Documents
Ochiya, T. 2010: Novel mechanisms of drug resistance in cancer Seikagaku. Journal of Japanese Biochemical Society 82(1): 34-38Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Courcambeck, J.ér.ôm.; Bouzidi, M.; Perbost, R.ég.; Jouirou, B.; Amrani, N.; Cacoub, P.; Pèpe, G.ér.; Sabatier, J.-M.; Halfon, P. 2006: Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations Antiviral Therapy 11(7): 847-855
Larder, B. 2001: Mechanisms of HIV-1 drug resistance Aids 15(Suppl 5): S27-S34
Akiyama, S.-i. 2003: The new mechanisms and reversal of drug resistance Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(1): 1-8
Katalinić-Janković, V.; Obrovac, M. 2004: Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 58(4): 323-328
Singh, N. 2006: Drug resistance mechanisms in clinical isolates of Leishmania donovani Indian Journal of Medical Research 123(3): 411-422
Heinemann, U.; Kann, O.; Remy, S.; Beck, H. 2006: Novel mechanisms underlying drug resistance in temporal lobe epilepsy Advances in Neurology 97: 85-95
Habenicht, U.F.; Neumann, F.; el Etreby, M.F. 1991: Cancer of the prostate. Mechanisms of action of antiandrogens Acta Urologica Belgica 59(4): 1-10
Roznovanu, S.L.ăc.ăm.; Amălinci, C.; Rădulescu, D.ţa. 2005: Molecular mechanisms in hormone-resistant prostate cancer Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 109(3): 577-583
Naito, S.; Shiota, M. 2014: The concept and mechanisms of castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2090-2094
Komiya, A.; Yasuda, K.; Watanabe, A.; Fuse, H. 2011: Basic mechanisms of androgen-independent growth in the prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 5): 96-103
Ying, H.-c.; Zhang, S.-l.; Jiang, T.; Ouyang, L.; Lü, J. 2007: Mechanisms of drug resistance in human ovarian carcinoma studied by comparative genomic hybridization Zhonghua Yi Xue Za Zhi 87(15): 1009-1012
Arai, Y.; Ogawa, O. 2019: Hormone Therapy and Castration Resistance of Prostate Cancer Canadian Journal of Urology 26(2): 9686
Govorin, N.V.; Lozhkina, A.N. 1991: Antibodies to neuroleptics and their role in the mechanisms of the development of drug resistance in psychopharmacotherapy of patients with paranoid schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 91(7): 117-121
Urasaki, Y.; Ueda, T.; Yoshida, A.; Fukushima, T.; Takeuchi, N.; Tsuruo, T.; Nakamura, T. 1996: Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms Anticancer Research 16(2): 709-714
Gomella, L.G. 2011: Name that prostate cancer drug Canadian Journal of Urology 18(3): 5666
Ripple, G.H.; Wilding, G. 1999: Drug development in prostate cancer Seminars in Oncology 26(2): 217-226
de la Torre, M.; Hao, X.Y.; Larsson, R.; Nygren, P.; Tsuruo, T.; Mannervik, B.; Bergh, J. 1993: Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases Anticancer Research 13(5a): 1425-1430
Meliksetian, M.B.; Berezkina, E.V.; Pavlenko, M.A.; Grinchuk, T.M. 1999: Mechanisms of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase Ii inhibitors adriamycin and etoposide Tsitologiia 41(7): 615-621